Effects of garlic oil on platelet aggregation: A double blind placebo controlled crossover study

Platelets

Volumn 18, Issue 1, 2007, Pages 29-34

  Wojcikowski, Ken ^a   Myers, Stephen ^a   Brooks, Lyndon ^a  

^a SOUTHERN CROSS UNIVERSITY   (Australia)

Author keywords

Antiplatelet; Clinical trial; Garlic; Platelet aggregation

Indexed keywords

1,3 VINYLDITHIIN (2 VINYL 4H 1,3 DITHIIN); ADENOSINE DIPHOSPHATE; ADRENALIN; AJOENE; ALCOHOL; ALLICIN; ANTITHROMBOCYTIC AGENT; COLLAGEN; GARLIC OIL; ORGANOSULFUR DERIVATIVE; PLACEBO; SOLVENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ISOLATION; FAINTNESS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL RESEARCH; METHODOLOGY; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADMINISTRATION, ORAL; ADULT; ALLYL COMPOUNDS; CAPSULES; COLLAGEN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EPINEPHRINE; ERUCTATION; ETHANOL; FEMALE; FOOD, FORMULATED; HUMANS; MALE; NAUSEA; PLANT EXTRACTS; PLATELET AGGREGATION; SULFIDES; SULFINIC ACIDS;

ALLIUM SATIVUM;

EID: 33847029609     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100600800636     Document Type: Article

References (27)

1. Watkins LO. Epidemiology and burden of cardiovascular disease. Clin Cardiol 2004;27:2-6.
2. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81-106.
3. Sztriha LK, Sas K, Vecsei L. Aspirin resistance in stroke. 2004. J Neurol Sci 2005;229:163-169.
4. Lee PY, Chen WH, Ng W, Cheng X, Kwok JY, Tse HF, Lau CP. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med 2005;118:723-727.
5. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Br Med J 1994;308:159-168.
6. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 1994;308:235-246.
7. Pierre S, Crosbie L, Duttaroy AK. Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro. Platelets 2005;16:469-473.
8. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001;161:813-824.
9. Alder R, Lookinland S, Berry JA, Williams M. A systematic review of the effectiveness of garlic as an anti-hyperlipidemic agent. J Am Acad Nurse Pract 2003;15:120-129.
10. Lawson LD, Ransom DK, Hughes BG. Inhibition of whole blood platelet-aggregation by compounds in garlic clove extracts and commercial garlic products. Thromb Res 1992;65:141-156.
11. Sovova M, Sova P. Pharmaceutical importance of Allium sativum L. 1. Organic sulfur compounds and their transformation based on present knowledge. Ceska a Slovenska Farmacie 2001;50:12-20.
12. Iberl B, Winkler G, Knobloch K. Ajoenes and dithiins, characterization and their determination by HPLC. Planta Med 1990;56:202-211.
13. Apitz-Castro R, Cabrera S, Cruz MR, Ledezma E, Jain MK. Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure. Thromb Res 1983;32:155-169.
14. Lawson LD, Wood SG, Hughes BG. HPLC analysis of allicin and other thiosulfinates in garlic clove homogenates. Planta Med 1991;57:263-270.
15. Egen-Schwind C, Eckard R, Jekat FW, Winterhoff H. Pharmacokinetics of vinyldithiins, transformation products of allicin. Planta Med 1992;58:8-13.
16. Srivastava KC, Tyagi OD. Effects of a garlic-derived principle (ajoene) on aggregation and arachidonic acid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids 1993;49:587-595.
17. Born GVR. Aggregation of platelets by adenosine diphosphate and its reversal. Nature 1962;194:927-929.
18. Breddin HK. Can platelet aggregometry be standardized?. Platelets 2005;16:151-158.
19. Goldstein H. Multilevel statistical models. 2nd ed. London: Edward Arnold; 1995.
20. Snijders TAB, Bosker RJ. An introduction to basic and advanced multilevel modeling. London: Sage; 1999.
21. Bordia A, Verma SK, Srivastava KC. Effect of garlic on platelet aggregation in humans: A study in healthy subjects and patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1996;55:201-205.
22. Malhotra S, Sharma YP, Grover A, Majumdar S, Hanif SM, Bhargava VK, Bhatnagar A, Pandhi P. Effect of different aspirin doses on platelet aggregation in patients with stable coronary artery disease. Intern Med J 2003;33:350-354.
23. Legnani C, Frascaro M, Guazzaloca G, Ludovici S, Cesarano G, Coccheri S. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects. Arzneimittelforschung 1993;43:119-122.
24. Boullin DJ. Garlic as a platelet inhibitor. Lancet 1981;i:776-777.
25. Lachmann G, Lorenz D, Radeck W, Steiper M. [The pharmacokinetics of the S35 labeled labeled garlic constituents alliin, allicin and vinyldithiine]. Arzneimittelforschung 1994;44:734-743.
26. Teranishi K, Apitz-Castro R, Robson SC, Romano E, Cooper DK. Inhibition of baboon platelet aggregation in vitro and in vivo by the garlic derivative, ajoene. Xenotransplantation 2003;10:374-379.
27. Sendl A, Elbl G, Steinke B, Redl K, Breu W, Wagner H. Comparative pharmacological investigations of Allium ursinum and Allium sativum. Planta Med 1992;58:1-7.